These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 28661936)
1. Revisiting the role of steroids and aspirin in the management of acute Kawasaki disease. Dhanrajani A; Yeung RSM Curr Opin Rheumatol; 2017 Sep; 29(5):547-552. PubMed ID: 28661936 [TBL] [Abstract][Full Text] [Related]
2. Kawasaki disease: a comprehensive review of treatment options. Patel RM; Shulman ST J Clin Pharm Ther; 2015 Dec; 40(6):620-5. PubMed ID: 26547265 [TBL] [Abstract][Full Text] [Related]
3. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children. Wooditch AC; Aronoff SC Pediatrics; 2005 Oct; 116(4):989-95. PubMed ID: 16199713 [TBL] [Abstract][Full Text] [Related]
5. Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol. Eleftheriou D; Moraes YC; Purvis C; Pursell M; Morillas MM; Kahn R; Mossberg M; Kucera F; Tulloh R; Standing JF; Swallow V; McCormack R; Herberg J; Levin M; Wan M; Klein N; Connon R; Walker AS; Brogan P Trials; 2023 Jan; 24(1):60. PubMed ID: 36703139 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological therapy for patients with Kawasaki disease. Williams RV; Minich LL; Tani LY Paediatr Drugs; 2001; 3(9):649-60. PubMed ID: 11688596 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Newburger JW; Takahashi M; Gerber MA; Gewitz MH; Tani LY; Burns JC; Shulman ST; Bolger AF; Ferrieri P; Baltimore RS; Wilson WR; Baddour LM; Levison ME; Pallasch TJ; Falace DA; Taubert KA; Pediatrics; 2004 Dec; 114(6):1708-33. PubMed ID: 15574639 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Newburger JW; Takahashi M; Gerber MA; Gewitz MH; Tani LY; Burns JC; Shulman ST; Bolger AF; Ferrieri P; Baltimore RS; Wilson WR; Baddour LM; Levison ME; Pallasch TJ; Falace DA; Taubert KA; ; ; ; Circulation; 2004 Oct; 110(17):2747-71. PubMed ID: 15505111 [TBL] [Abstract][Full Text] [Related]
9. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease. Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843 [TBL] [Abstract][Full Text] [Related]
10. Advances in the treatment of Kawasaki disease. Dominguez SR; Anderson MS Curr Opin Pediatr; 2013 Feb; 25(1):103-9. PubMed ID: 23283289 [TBL] [Abstract][Full Text] [Related]
11. Recent advances in the treatment of Kawasaki disease. Weng KP; Ou SF; Lin CC; Hsieh KS J Chin Med Assoc; 2011 Nov; 74(11):481-4. PubMed ID: 22100015 [TBL] [Abstract][Full Text] [Related]
12. Kawasaki disease. Scuccimarri R Pediatr Clin North Am; 2012 Apr; 59(2):425-45. PubMed ID: 22560578 [TBL] [Abstract][Full Text] [Related]
13. Aspirin Dose in Kawasaki Disease: The Ongoing Battle. Dhanrajani A; Chan M; Pau S; Ellsworth J; Petty R; Guzman J Arthritis Care Res (Hoboken); 2018 Oct; 70(10):1536-1540. PubMed ID: 29287309 [TBL] [Abstract][Full Text] [Related]
14. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial. Tremoulet AH; Jain S; Jaggi P; Jimenez-Fernandez S; Pancheri JM; Sun X; Kanegaye JT; Kovalchin JP; Printz BF; Ramilo O; Burns JC Lancet; 2014 May; 383(9930):1731-8. PubMed ID: 24572997 [TBL] [Abstract][Full Text] [Related]
15. Kawasaki disease: part II. Complications and treatment. Bayers S; Shulman ST; Paller AS J Am Acad Dermatol; 2013 Oct; 69(4):513.e1-8; quiz 521-2. PubMed ID: 24034380 [TBL] [Abstract][Full Text] [Related]
17. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited. Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617 [TBL] [Abstract][Full Text] [Related]
18. A meta-analysis on the effect of corticosteroid therapy in Kawasaki disease. Zhu BH; Lv HT; Sun L; Zhang JM; Cao L; Jia HL; Yan WH; Shen YP Eur J Pediatr; 2012 Mar; 171(3):571-8. PubMed ID: 22057683 [TBL] [Abstract][Full Text] [Related]
19. Coronary Artery Complication in Kawasaki Disease and the Importance of Early Intervention : A Systematic Review and Meta-analysis. Chen S; Dong Y; Kiuchi MG; Wang J; Li R; Ling Z; Zhou T; Wang Z; Martinek M; Pürerfellner H; Liu S; Krucoff MW JAMA Pediatr; 2016 Dec; 170(12):1156-1163. PubMed ID: 27749951 [TBL] [Abstract][Full Text] [Related]
20. Intravenous Immunoglobulin for the Treatment of Kawasaki Disease. Shulman ST Pediatr Ann; 2017 Jan; 46(1):e25-e28. PubMed ID: 28079915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]